EnCare Biotech's Series A Round

EnCare Biotech raised a round of funding on November 21, 2014.

EnCare Biotech aims to develop a new therapeutic antibody for the prevention of heart failure after acute myocardial infarction (AMI; heart attack). Directly following AMI an inevitable inflammatory r…

Articles about EnCare Biotech's Series A Round: